A detailed history of Vestal Point Capital, LP transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,725,000 shares of VTYX stock, worth $3.92 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,725,000
Previous 1,315,000 31.18%
Holding current value
$3.92 Million
Previous $3.04 Billion 23.8%
% of portfolio
0.29%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.85 - $3.2 $758,500 - $1.31 Million
410,000 Added 31.18%
1,725,000 $3.76 Billion
Q2 2024

Aug 14, 2024

BUY
$2.31 - $5.59 $3.04 Million - $7.35 Million
1,315,000 New
1,315,000 $3.04 Billion

Others Institutions Holding VTYX

About Ventyx Biosciences, Inc.


  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $128M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.